The MedTalk Podcast – Détails, épisodes et analyse

In this episode, you can hear Olivia Friett, editor of Medical Plastics News talk to Elliot Justin, CEO at FirmTech, about sexual health wearables and how it can track multiple possible health conditions.

In this episode of The MedTalk Podcast, you can hear Olivia Friett, editor of Medical Plastics News talk to Murdoc Khaleghi, chief medical officer for Molecular You about the latest technology in AI driven blood testing and how it can detect early stages of diseases such as Alzheimer's.

Olivia Friett is joined by guests from recent and future episodes of the FemTech Series for International Women's Day to discuss the current landscape for women in medtech. The guests will cover the lack of female representation in medtech in both devices and executive positions, their personal experiences, what they hope the future holds for women in medtech, and more.

Ian and Reece are back, though they might be tripping over and getting their words muddled up, they talk about COVID-19 vaccines. Recorded on 19th March, the duo touch upon vaccine approvals, the stance of the European Union when it comes to vaccine protectionism, the safety of the AstraZeneca vaccine, and why Donald Trump is encouraging people to get the vaccine. There is also brief discussion about when a public inquiry in the handling of the pandemic should come about. With new issues of Med-Tech Innovation News and European Pharmaceutical Manufacturer landing, they offer a sneak peek of what their readers can expect.

Ian and Reece return with a new episode covering the latest Covid-19 news and what the UK government's 2021 Budget means for life sciences.

At the end of 2020, the European Commission released its Pharmaceutical Strategy, examining the challenges of medicines manufacturing in Europe including things such as drug shortages, sustainability, and the lessons that can be learned following the Covid-19 pandemic. Here, European Pharmaceutical Manufacturer editor Reece Armstrong speaks to Richard Daniell, head of commercial at Teva Europe about the strategy and some of the most important points for improving manufacturing for medicines across Europe.

Med-Tech Innovation News editor Ian Bolland speaks to Amy Lovegrove, director of UK clinical operations, and Tash Brown, marketing manager at iRhythm Technologies, to discuss its offering the in the field of stroke and cardiac care through its Zio device. They also discuss how Zio has been used during the Covid-19 pandemic, technological adoption in the NHS, and whether the pandemic has accelerated technological advancement and adoption for patients and service providers.

Recorded before they got a chance to thank Matt Hancock, Ian and Reece are back to discuss more news related to the pandemic, as well as another potential re-organisation in the NHS, investment in the UK life sciences sector and another report surrounding the digitisation of healthcare and medical technologies. You can read the reports mentioned in this episode below: Public Policy Projects: Digitisation of Healthcare and Medical Technologies https://publicpolicyprojects.com/blog/publications/digitisation-of-healthcare-and-medical-technologies/ Life Sciences Competitiveness Indicators 2020 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963220/Life_Science_Competitiveness_Indicators_2020_report.pdf NHS Whitepaper – Working together to improve health and social care for all https://www.gov.uk/government/publications/working-together-to-improve-health-and-social-care-for-all

Med-Tech Innovation News editor Ian Bolland is joined by Nooman Haque, the Managing Director of Life Sciences and Healthcare at Silicon Valley Bank’s UK branch, as they discuss the company’s healthcare investments and exits report. In 2020, both venture capital fundraising and investment in healthcare companies surged to record levels globally. An unprecedented $17.1 billion was raised in new venture funds dedicated to the sector, representing a 57% year-on-year increase from 2019’s total of $10.7 billion. The pace of investment in the UK also increased and the total by the end of the third quarter of 2020 exceeded the total number of deals for the whole of 2019. Nooman and Ian discuss the report in more detail, whether this boom in investments is here to stay, and what to look out for in 2021 and beyond.

After a long hiatus, Med-Tech Innovation editor Ian Bolland and European Pharmaceutical Manufacturer editor Reece Armstrong sit down to discuss the Covid-19 vaccines landscape in the UK and beyond.